Evaluation of the efficacy and tolerance of R 018893, R 089439 (loviride) and placebo in asymptomatic HIV-1-infected patients. Loviride Collaborative Study Group

Antivir Ther. 1996 Jan;1(1):42-50.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Acetamides / adverse effects
  • Acetamides / therapeutic use*
  • Acetophenones / adverse effects
  • Acetophenones / therapeutic use*
  • Anti-HIV Agents / therapeutic use*
  • Biomarkers / blood
  • CD4 Lymphocyte Count
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • HIV Infections / blood
  • HIV Infections / drug therapy*
  • HIV-1* / genetics
  • HIV-1* / isolation & purification
  • Humans
  • Inhibitory Concentration 50
  • Lymphocyte Subsets
  • Male
  • Neopterin / blood
  • Receptors, Interleukin-2 / blood
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Treatment Refusal

Substances

  • Acetamides
  • Acetophenones
  • Anti-HIV Agents
  • Biomarkers
  • Receptors, Interleukin-2
  • Reverse Transcriptase Inhibitors
  • loviride
  • Neopterin